COURSE DIRECTOR
Mark A. Edgar, M.D.

DESCRIPTION
The Autopsy Conference will meet quarterly and is open to Internal Medicine Residents, Fellows & Chiefs; Internal Medicine faculty; Surgical Pathology fellows; Pathology Assistants; Pathology Faculty; visiting students/residents/fellows who are on internal medicine or pathology rotations. 

TARGET AUDIENCE
This activity is intended primarily for physicians, resident/fellows, and scientists.

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:

• Identify the possible causes of death that may not be readily apparent clinically in the patient.
• Integrate unexpected findings at autopsy during the conference by consulting with the internal medicine residents/fellows.
• Assess the medical care that was given and determine if a change could have been made with the
  additional information received at autopsy.
• Formulate a plan to integrate the unexpected findings in future care of patients.

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Statement(s): 
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DISCLOSURE SUMMARY
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities.  All who are in a position to control the content are required to disclose all financial relationships with any ineligible company.   Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.

Listed below are individuals with control of the content of this program who have disclosed...

Relevant financial relationship(s) with ineligible companies:
None

All relevant financial relationships listed for these individuals have been mitigated.

No relevant financial relationship(s) with ineligible companies:
Ishaq A. Asghar, M.B.B.S. (added 8.06.24)
Hanae Benchbani, M.D. (added 8.06.24)
Mark A. Edgar, M.D.
Basma M. Elhaddad, M.B., B.Ch., M.S. (inactive 7.13.24)
Khela Pursell, PA(ASCP)
J. Kenneth Schoolmeester II, M.D.
Meredith R. Brown (Coordinator)
Nicole M. Donnelly (Coordinator)
Lorraine M. Hutcherson (Coordinator)

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None

CE Broker Code: 24R00749

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

QUESTIONS
Contact Meredith Brown